Wenbin Wei Selected Research

Wenbin Wei Research Topics

Disease

42	Neoplasms (Cancer) 01/2024 - 05/2002
10	Hodgkin Disease (Hodgkin's Disease) 08/2018 - 09/2005
8	Melanoma (Melanoma, Malignant) 01/2022 - 04/2010
7	Epstein-Barr Virus Infections 01/2017 - 09/2005
6	Uveal melanoma 04/2022 - 04/2011
6	Lymphoma (Lymphomas) 01/2022 - 03/2007
6	Infections 12/2021 - 02/2009
4	Leishmaniasis 01/2022 - 01/2021
4	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2019
4	Carcinogenesis 01/2019 - 03/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 02/2024 - 11/2021
3	Myopia 01/2023 - 01/2017
3	Retinal Detachment (Retinal Detachments) 01/2022 - 03/2014
3	Macular Edema 01/2021 - 01/2014
3	Carcinoma (Carcinomatosis) 01/2020 - 05/2009
3	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 01/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 10/2011
2	Blindness (Hysterical Blindness) 04/2024 - 04/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 12/2019
2	Choroidal Neovascularization 04/2023 - 01/2014
2	Atrophy 04/2023 - 01/2023
2	Fibrosis (Cirrhosis) 04/2023 - 02/2010
2	Hypoxia (Hypoxemia) 01/2023 - 07/2015
2	Cytomegalovirus Retinitis 12/2022 - 11/2021
2	Wounds and Injuries (Trauma) 09/2022 - 01/2019
2	Cataract (Cataracts) 07/2022 - 01/2022
2	Trigeminal Neuralgia (Tic Douloureux) 01/2022 - 07/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
2	Glaucoma 01/2021 - 08/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2021
2	Disease Progression 01/2020 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 11/2019 - 01/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2019 - 03/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 09/2004
2	Nasopharyngeal Carcinoma 01/2017 - 02/2015
2	Retinal Telangiectasis 06/2016 - 01/2016
2	Inflammation (Inflammations) 07/2015 - 11/2008
2	Breast Neoplasms (Breast Cancer) 06/2015 - 03/2007
2	Retinal Perforations 03/2014 - 01/2014
2	Adenocarcinoma 03/2013 - 11/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2011 - 02/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2010 - 06/2008
1	Bietti Crystalline Dystrophy 04/2024
1	Optic Nerve Diseases (Optic Neuropathy) 04/2024
1	Anisometropia 03/2024
1	Exotropia (Exophoria) 03/2024
1	Demyelinating Diseases (Demyelinating Disease) 03/2024
1	Dry Eye Syndromes (Dry Eye Syndrome) 02/2024

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2023 - 09/2004
12	Biomarkers (Surrogate Marker)IBA 04/2023 - 06/2006
8	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
7	Retinaldehyde (Retinal)IBA 04/2024 - 01/2014
4	AntigensIBA 12/2020 - 04/2010
4	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2011
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2009
3	LipidsIBA 02/2024 - 03/2013
3	CollagenIBA 04/2023 - 03/2007
3	CytokinesIBA 12/2022 - 11/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 12/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 02/2009
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2020 - 04/2010
3	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2014
3	ProteomeIBA 09/2015 - 06/2006
2	LigandsIBA 03/2024 - 11/2013
2	Fluorescein (Funduscein)FDA LinkGeneric 02/2024 - 12/2020
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2024 - 12/2019
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2024 - 01/2017
2	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2019
2	Iodine-125IBA 04/2022 - 01/2013
2	EnzymesIBA 01/2022 - 01/2017
2	Cadherins (E-Cadherin)IBA 12/2021 - 11/2012
2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	SynaptophysinIBA 12/2020 - 04/2010
2	Melanins (Melanin)IBA 12/2020 - 10/2020
2	Phosphopyruvate Hydratase (Enolase)IBA 12/2020 - 04/2010
2	VimentinIBA 12/2020 - 04/2010
2	CD40 Ligand (CD40L)IBA 01/2020 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 09/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2018 - 08/2013
2	Glycoproteins (Glycoprotein)IBA 09/2015 - 02/2014
2	Peptides (Polypeptides)IBA 03/2013 - 10/2011
2	MethyltransferasesIBA 07/2012 - 09/2011
2	NF-kappa B (NF-kB)IBA 03/2007 - 09/2004
1	Monoclonal AntibodiesIBA 01/2024
1	Rituximab (Mabthera)FDA Link 01/2024
1	ofatumumab FDA Link 01/2024

Therapy/Procedure

17	Therapeutics 04/2024 - 05/2009
7	Vitrectomy 07/2022 - 03/2014
5	Lasers (Laser) 01/2021 - 03/2007
4	Radiotherapy 04/2022 - 01/2013
4	Brachytherapy 01/2022 - 01/2013
3	Injections 12/2022 - 01/2020
3	Counterpulsation (External Counterpulsation) 01/2021 - 01/2020
2	Telescopes 03/2024 - 04/2002
2	Intravitreal Injections 01/2023 - 01/2022
2	Aftercare (After-Treatment) 12/2022 - 01/2021
2	Vitreoretinal Surgery 09/2022 - 05/2002
2	Light Coagulation 01/2021 - 06/2016
1	Highly Active Antiretroviral Therapy (HAART) 02/2024